- Abstract Number: 1907
T-Bet Regulates Ahr-Mediated Th-17 Differentiation Independently of IFNγ
- Abstract Number: 2923
T-Cell Receptor Signaling Inhibition By CC-90005, a Selective Protein Kinase C Theta Antagonist, Reduces Antigen Mediated T-Cell Activation and Arthritis Pathology in the Mouse CIA Model
- Abstract Number: 2222
Tai Chi Is More Effective Than Aerobic Exercise in Treating Fibromyalgia: A Randomized Controlled Trial
- Abstract Number: 50
Tai Chi Significantly Modulates Resting State Functional Connectivity of the Cognitive Control Network in Fibromyalgia
- Abstract Number: 864
Takayasu Arteritis Developed over the Age of 40 Has Lower Levels of Interferon Gamma and Interleukin 17 at Disease Onset and Fewer Subsequent Relapses
- Abstract Number: 2702
Taking Fly for Understanding the Molecular Role of HLA-B27/hB2m in Spondyloarthritis
- Abstract Number: 1097
Tankyrase Regulates Osteoclastogenesis Via SH3BP2
- Abstract Number: 3014
Tapering of Adalimumab Based on Therapeutic Drug Monitoring in Rheumatoid Arthritis
- Abstract Number: 1125
Targeted Lipidomics Reveals Incomplete Activation of Resolution Pathways in Knee Osteoarthritis
- Abstract Number: 1123
Targeted Mutations Identify the Active Site of Glucocorticoid-Induced Leucine Zipper (GILZ)
- Abstract Number: 1213
Targeted Next-Generation Sequencing of 128 Genes Associated with Rheumatoid Arthritis
- Abstract Number: 3177
Targeted Nuclear Imaging for the Early Detection of Lung Involvement in Systemic Sclerosis
- Abstract Number: 852
Targeting Fibroblastoid-like Cells By Drug Loaded Engineered Gold Nanoparticles As a Novel Approach for ILD-SSc Treatment
- Abstract Number: 674
Targeting Glandular IL-21-Production in Primary Sjogren′s Syndrome Patients By Immunomodulatory Treatment
- Abstract Number: 1109
Targeting IL-8 and CXCR1/2 Abrogates RANKL- and ACPA-Mediated Osteoclastogenesis
- Abstract Number: 2791
Targeting Micro-RNAs Derived from Extracellular Vesicles to Inhibit of TLR7 and TLR8 Signaling Suppresses Inflammation in a Novel Human-Mouse Chimeric Model of Systemic Lupus Erythematosus
- Abstract Number: 2107
Targeting Mir-155 in Rheumatoid Arthritis B Cells Reduces Antibody Production
- Abstract Number: 1033
Targeting Notch-Activated M1 Macrophages Attenuates Joint Tissue Damage in a Mouse Model of Inflammatory Arthritis
- Abstract Number: 1881
Targeting Oncostatin M in the Target Tissue: Assessment of in-Vivo Affinity and Target Engagement of an Anti-OSM Monoclonal Antibody By Combining Blood and Skin Blister Fluid Data
- Abstract Number: 484
Targeting the BTK-JAK Axis in Preclinical Models of Rat Collagen-Induced Arthritis with GS-4059 in Combination with a JAK Inhibitor
- Abstract Number: 460
TAS5315, a Novel Bruton’s Tyrosine Kinase Inhibitor, Demonstrates Anti-Inflammatory Effect in Autoimmune Disease Models
- Abstract Number: 1436
TAS8274, a Highly Selective Janus Kinase 3 Inhibitor, Demonstrates Potent Efficacy in an Animal Model of Rheumatoid Arthritis
- Abstract Number: 2599
TCZ Improves the Pro-Atherothrombotic Profile of Rheumatoid Arthritis Patients Modulating Endothelial Dysfunction, Netosis and Inflammation
- Abstract Number: 577
TCZ Modulates the Production of Ccfdna Derived from RA Synovial Cells
- Abstract Number: 439
Temple University Hospital Rheumatology Narcotic Contract
- Abstract Number: 903
Temporal Arteritis: Is There Any Correlation Between Ultrasonographic Arterial Wall Involvement and the Inflammatory Cellular Infiltrate at Histological Examination?
- Abstract Number: 1530
Temporal Trend of Total Joint Replacement in Rheumatoid Arthritis Patients: A Survival Study
- Abstract Number: 3172
Temporal Trends in SLE Mortality According to Sex, Race, Ethnicity, and Geographic Region in the United States over the Past Five Decades
- Abstract Number: 2498
Tender Joints Is a Consistent Negative Predictor of Sustained Remission in Aggressively Treated Patients with Early Rheumatoid Arthritis
- Abstract Number: 1100
Tenofovir, a Nucleoside Analog Reverse Transcriptase Inhibitor for Treatment of HIV, Promotes Osteoclast Differentiation and Decreases Osteoblast Formation By a Mechanism Depending on ATP Release and Adenosine
- Abstract Number: 2141
Terminal Uridylyl Transferase ZCCHC6-Dependent Generation of miRNA Diversity in Primary Human Chondrocytes
- Abstract Number: 2924
Terminally Differentiated CD8 T Cell Subset Has Distinct Signiture in RA
- Abstract Number: 867
Termination of Tocilizumab-Treatment in Giant Cell Arteritis: Follow-up of Patients after the RCT (ClinicalTrials.gov registration number: NCT01450137)
- Abstract Number: 1106
Test of the Spleen Tyrosine Kinase Inhibitor Fostamatinib in a Translational Joint Tissue Model Show Significant Effect on Bone, but Not on Synovial Tissue
- Abstract Number: 1845
TGF-β-Induced Tissue Fibrosis Is Abrogated in Mice Containing a Constitutive Genetic Deletion of Nox4 (Nox4 knockout)
- Abstract Number: 3040
Th17 Migration into the Synovial Fluid of Patients with Active Psoriatic Arthritis Is Enhanced By Regulatory T Cells
- Abstract Number: 2248
The “Financial Toxicity” of Therapy in Patients with Rheumatoid Arthritis
- Abstract Number: 493
The 2010 ACR/EULAR Criteria Are Not Sufficiently Accurate in the Early Identification of Autoantibody-Negative Rheumatoid Arthritis
- Abstract Number: 102
The 2015 American College of Rheumatology (ACR) Workforce Study: A Snapshot of Academic Division Directors
- Abstract Number: 136
The 7-Joints Musculoskeletal Ultrasound Score (US7 score) Predicts Therapeutic Change in Patients with Early Rheumatoid Arthritis
- Abstract Number: 135
The 8-Joint Ultrasound Score Is a Useful Marker for Monitoring Therapeutic Response in Rheumatoid Arthritis
- Abstract Number: 1777
The Accumulation of Organ Damage, Public Insurance Enrollment and Youth Are Associated with Increased Hospitalizations in a Population-Based Cohort of Lupus Patient
- Abstract Number: 322
The Activating Patients at Risk for Osteoporosis Study: A Randomized Trial within the Global Longitudinal Study of Osteoporosis in Women Cohort
- Abstract Number: 3018
The Analysis of Severity of Arthritis in the Intestinal Microbiota-Humanized Mice
- Abstract Number: 449
the Animated Activity Questionnaire to Assess Activity Limitations in Patients with Hip and Knee Osteoarthritis: Reliability, Responsiveness, and Interpretation
- Abstract Number: 1085
The Anti-CD38 Monoclonal Antibody TAK-079 Depletes Antibody Secreting Cells from Normal and SLE Patients
- Abstract Number: 921
The Anti-IL-17A Antibody Secukinumab (Cosentyx®, AIN457) Diminishes the Expression of the NFκB Pathway Modulator Iκbζ
- Abstract Number: 165
The Apparent Diffusion Coefficient As a Quantitative Imaging Biomarker of Therapeutic Response in Enthesitis-Related Arthritis
- Abstract Number: 2101
the Association Between ABO Blood Types and Venous Thromboembolism in Individuals with a Positive Antiphospholipid Antibody Profile Is Varied By Sex
- Abstract Number: 2194
The Association Between Arthritis and Carpal Tunnel Syndrome: National Health Interview Survey, 2010
- Abstract Number: 3161
The Association Between HLA Genetic Susceptibility Markers and Sonographic Enthesitis in Psoriatic Arthritis
- Abstract Number: 1662
The Association Between Radiologic Progression and Serum Levels of Potential Markers of Bone Formation in Ankylosing Spondylitis Patients
- Abstract Number: 3157
The Association Between Sonographic Enthesitis and Radiographic Damage in Psoriatic Arthritis
- Abstract Number: 2189
The Association of Arthritis and Lung Diseases: A Population-Based Study
- Abstract Number: 515
The Association of Body Mass Index with the Severity of Magnetic Resonance Imaging-Detected Inflammation at Presentation; Opposite Effects in Early Rheumatoid Arthritis Compared to Other Arthritides and an Asymptomatic Population
- Abstract Number: 1552
The Association of Fatigue, Comorbidities and Anti Rheumatic Drugs in Rheumatoid Arthritis: Results from French Cohort Study of Comorbidities
- Abstract Number: 2027
The Association of Light and Moderate-to-Vigorous Walking with Incident Poor Health Outcomes over Two Years in People with or at High Risk of Knee Osteoarthritis
- Abstract Number: 359
The Association of Scheuermann’s Disease with Osteoporotic Vertebral Fracture Risk
- Abstract Number: 2360
The Association of Superolateral Hoffa’s Fat Pad Edema and Synovitis with Structural Changes in the Patellofemoral and Tibiofemoral Joints: The Multicenter Osteoarthritis Study
- Abstract Number: 2929
The Baseline Th17 Lymphocytes Level Is a Predictive Marker of Good Response to Biologics in Rheumatoid Arthritis
- Abstract Number: 1L
The Cardiovascular Safety of Celecoxib Versus Ibuprofen or Naproxen in 24,081 Patients with Osteoarthritis or Rheumatoid Arthritis
- Abstract Number: 3143
The Caspase 8/RIPK3 Signaling Axis in Dendritic Cells Controls Joint Homeostasis Under Steady-State and Arthritic Conditions
- Abstract Number: 2883
The CD4+CD52low T Cell Contributes to the Development of Systemic Lupus Erythematosus through the CCR8/TARC Pathway
- Abstract Number: 3079
The Characteristic Features of the Patients with Deficiency of Adenosine Deaminase 2 (DADA2)
- Abstract Number: 3004
The Choosing Wisely Initiative: Is It Complete?
- Abstract Number: 314
The Clinical Efficacy and Safety of the Gumiganhwal-Tang in Knee Osteoarthritis: A Phase II Randomized Double Blind Placebo Controlled Study
- Abstract Number: 2918
The Clinical Relevance of Common ANA Patterns in Systemic Sclerosis
- Abstract Number: 607
The Clinical Response to Biologic and Non-Biologic Disease Modifying Antirheumatic Drugs (DMARDs) According to Gender in a French-Canadian Population with Rheumatoid Arthritis (RA)
- Abstract Number: 2322
The Clinical Significance of Curvilinear Bodies on Ultrastructural Examination of Muscle
- Abstract Number: 2366
The Clinical Utility of the Bulge Sign in Evaluating Knee Osteoarthritis
- Abstract Number: 2723
The Co-Occurrence of Axial Spondyloarthritis and Fibromyalgia: A National Register-Based Study
- Abstract Number: 1581
The Combination of IL-6 and IL-6 Receptor Levels As a Biomarker of Response to Tocilizumab in Rheumatoid Arthritis Patients
- Abstract Number: 1691
The Comparative Immunogenicity of Biologic Therapy and Its Clinical Relevance in Psoriatic Arthritis: A Systematic Review of the Literature
- Abstract Number: 1564
The Comprehensive Analysis for the Transcriptional Organization of Stimuli Responses in Fibroblast-like Synoviocytes from Rheumatoid Arthritis Patients
- Abstract Number: 1879
The Correlation Between Oxidized Low-Density Lipoprotein and Clinical Manifestations in Patients with Systemic Sclerosis
- Abstract Number: 1223
The Cost of Confronting Osteoporosis:Cost Study of a Fracture Liaison Service
- Abstract Number: 1081
The CRL4CRBN E3 Ubiquitin Ligase Modulator CC-220 Inhibits BAFF-Mediated Plasmablast Differentiation and Immunoglobulin Secretion from Class Switched CD27+IgD- Memory and Lupus-Associated CD27-IgD- Double Negative B-Cells
- Abstract Number: 2365
The Cross-Sectional and Longitudinal Associations Between Metabolic Syndrome and Hand Osteoarthritis – Data from the Framingham Study
- Abstract Number: 532
The DAS28 Score May Misread Disease Activity in Rheumatoid Arthritis Patients
- Abstract Number: 3207
The Deficiency of Adenosine Deaminase Type 2 (DADA2)—Results of Anti-TNF Treatment in a Cohort of Patients with a History of Stroke
- Abstract Number: 2407
The Descriptive Epidemiology of Acute Rheumatic Fever and Post-Streptococcal Reactive Arthritis in Japan
- Abstract Number: 1607
The Development of a New Anti–Interleukin 6 Blocker for Rheumatoid Arthritis Patients
- Abstract Number: 1165
The Development of an Interdisciplinary Treatment Program for Fibromyalgia in a Tertiary Medical Center Focused upon Rheumatology and Internal Medicine
- Abstract Number: 3151
The Diagnostic and Predictive Value of Anti-Acetylated Peptide Antibodies in RA Patients Starting Methotrexate Treatment
- Abstract Number: 711
The Diagnostic Value of the Symptom of Inflammatory Back Pain in the Rheumatology Setting
- Abstract Number: 2376
The Disease Burden of Systemic Juvenile Idiopathic Arthritis for Patients and Caregivers: An International Health Related Quality of Life Survey and Retrospective Chart Review
- Abstract Number: 854
The Ducas: Proposal for a Digital Ulcer Assessment Score in Scleroderma
- Abstract Number: 754
The Duration of Anti-Malarial Agent Intake in the First 5 Years of the Disease and Prognosis in Patients with Systemic Lupus Erythematosus
- Abstract Number: 1237
The Economic Burden of Dermatomyositis and Polymyositis in the US
- Abstract Number: 2009
The Effect of Anifrolumab on Cutaneous Manifestations and Arthritis in Moderate to Severe Systemic Lupus Erythematosus (SLE) Using Categorical SLEDAI–2K Responses and Continuous Measures of Activity As Outcome Measures
- Abstract Number: 2494
The Effect of Body Mass on DAS28 Response in Patients with Rheumatoid Arthritis Treated with Abatacept
- Abstract Number: 1724
The Effect of Certolizumab Pegol on Skin Manifestations of Psoriatic Arthritis over 4 Years of Treatment
- Abstract Number: 1872
The Effect of Cyclophosphamide on Pulmonary Function and Dependence on Disease Activity of Interstitial Lung Disease Associated with Systemic Sclerosis
- Abstract Number: 2567
The Effect of Fibroblast Growth Factor 4 on the Proliferation of Fibroblast-like Synoviocytes in Rheumatoid Arthritis
- Abstract Number: 3025
The Effect of Filgotinib (GLPG0634), an Oral JAK1 Selective Inhibitor on Patient-Reported Outcomes: Results from Two 24-Week Phase 2B Dose Ranging Studies
- Abstract Number: 2627
The Effect of Fostamatinib with Methotrexate on Circulating Biomarkers of Synovium, Cartilage and Bone Metabolism: Potential Utility for Clinical Development Decision Making in Rheumatoid Arthriti
- Abstract Number: 361
The Effect of Immunosuppressive and Antiresorptive Therapy on Bone Mineral Density in Lung Transplant Patients
- Abstract Number: 1851
The Effect of Narrow Band Ultraviolet A1 Light on Bleomycin-Induced Mouse Model of Scleroderma
- Abstract Number: 1155
The Effect of Nurse-Led Follow-up in Rheumatoid Arthritis. a Systematic Review and Meta-Analysis of Randomized Controlled Trails
- Abstract Number: 2738
The Effect of Pregnancy on Disease Activity Outcomes in Psoriatic Arthritis Patients
- Abstract Number: 217
The Effect of Regular Treatment on Disability in a Cohort of Patients with Gout.
- Abstract Number: 2920
The Effect of Rituximab on B Cells in Skin and Peripheral Blood in Systemic Sclerosis
- Abstract Number: 2593
The Effect of Tofacitinib on Bone Mineral Density in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis
- Abstract Number: 956
The Effect of Treatment Adjustments Aimed at DAS Remission on Physical Functioning in Undifferentiated and Rheumatoid Arthritis Patients in Low Disease Activity
- Abstract Number: 114
The Effect of Triage Assessments on Identifying Inflammatory Arthritis and Reducing Rheumatology Wait Times in Ontario
- Abstract Number: 1523
The Effect Size of Fibromyalgia on PG-VAS in Rheumatoid Arthritis Patients. Adjustment Proposal in DAS28-ESR
- Abstract Number: 2315
The Effectiveness of Social Media in Recruiting for Rare Rheumatic Diseases
- Abstract Number: 2609
The Effectiveness of Zoster Vaccine in RA Patients Subsequently Treated up to 19 Months with Tofacitinib
- Abstract Number: 3026
The Efficacy and Safety of Low Dose IL-2 Therapy in over-Treated Patients with Rheumatoid Arthritis: A Preliminary Study
- Abstract Number: 2590
The Efficacy of Additional Immunoadsorption on the Modulation of Disease Activity in Patients with Severe Rheumatoid Arthritis
- Abstract Number: 452
The Efficacy of Motivational Counselling and SMS-Reminders on Daily Sitting Time in Patients with Rheumatoid Arthritis: A Randomised Controlled Trial
- Abstract Number: 1449
The Efficiency of the Regulation of Ca2+ Entry through Calcium Release-Activated Calcium Channel in the Treatment of Rheumatoid Arthritis
- Abstract Number: 2183
The Electronic Osteoarthritis Knee and Hip Quality of Life (OAKHQOL) Questionnaire: A Useful and Valid Alternative to Measure Health-Related Quality of Life in Knee Osteoarthritis
- Abstract Number: 1119
The Enhanced Expression of mRNA for Calgranulins, S100A8, S100A9 and S100A12, in CD34+ Cells of the Bone Marrow in Rheumatoid Arthritis
- Abstract Number: 1439
The EP4 Receptor Antagonist CR6086 Is More Effective Than Classical NSAID and DMARD Treatment in a Murine Model of Arthritis and in Human RA Synovial Explants
- Abstract Number: 1168
The Epidemiology of Individuals Not Fully Meeting Classification Criteria for Systemic Lupus Erythematosus (SLE): The Georgia Lupus Registry
- Abstract Number: 1432
The EULAR Systemic Sclerosis Impact of Disease Score – a New Patient-Reported Outcome Measure for Patients with Systemic Sclerosis Under Development
- Abstract Number: 2213
The Four Stages of Fibromyalgia: Potential for More Precise Treatment Approaches
- Abstract Number: 1964
The Frequency and Clinical Significance of IgA Anticardiolipin and Anti-β2-Glycoprotein-I Antibodies in Antiphospholipid Antibody Patients with and without Lupus
- Abstract Number: 2193
The Frequency of and Patient Characteristics Associated with Fear of Movement in Adults with Symptomatic Knee Osteoarthritis
- Abstract Number: 1140
The Future of Rheumatology: Pediatric and Adult Fellows-in-Training Results from the 2015 ACR/ARHP Workforce Study
- Abstract Number: 3015
The Good, the Bad and the Ugly – Refractory Rheumatoid Arthritis in 2016
- Abstract Number: 520
The HAQ Reversible and Irreversible Components Measuring Function in Rheumatoid Arthritis
- Abstract Number: 1794
The High Disease Activity State Is an Adverse Prognostic Indicator in SLE and Defines a Clinically Distinct Population
- Abstract Number: 497
The Identification of an ACR Score with the Optimal Discriminatory Ability Between Treatments in Patients with Early and Established Rheumatoid Arthritis
- Abstract Number: 269
The Immunoproteasomes Are Essential for Maintaining Myokine Production and MHC Class I Expression in Idiopathic Inflammatory Myopathies
- Abstract Number: 1179
The Impact of Autoimmune Disease in the Management and Prognosis of Acute Coronary Syndrome
- Abstract Number: 2592
The Impact of Biologic Therapy Introduction on Hip and Knee Replacement Among Rheumatoid Arthritis Patients: An Interrupted Time Series Analysis Using the Clinical Practice Research Datalink
- Abstract Number: 1770
The Impact of Comorbidities on Quality of Life in Systemic Lupus Erythematosus in the First 10 Years
- Abstract Number: 18
The Impact of Disease-Related and Contextual Factors on Work Outcomes in Chronic Inflammatory Arthritis Patients Treated with Biologics: A Systematic Review
- Abstract Number: 1019
The Impact of Hip and Knee Osteoarthritis on the Subsequent Risk of Incident Diabetes: A Population-Based Cohort Study
- Abstract Number: 992
The Impact of Inflammatory Arthritis (rheumatoid arthritis, spondyloarthritis, psoriatic arthritis, reactive arthritis) on Maternal and Neonatal Outcomes: A Population-Level Analysis
- Abstract Number: 3084
The Impact of Mental Health on Indicators of Disease Severity Among Patients with Inflammatory Arthritis: A Cross-Sectional and Longitudinal Investigation
- Abstract Number: 3054
The Impact of Obesity on Knee Osteoarthritis Symptoms and Related Biomarker Profiles in a Bariatric Surgery Cohort
- Abstract Number: 3171
The Impact of Statin Use on Mortality in Systemic Autoimmune Rheumatic Diseases
- Abstract Number: 17
The Importance of Achieving Clinical Response to Treatment and Changes in Physical Ability and Quality of Life on Worker Productivity Outcomes in Rheumatoid Arthritis: Results from the British Society for Rheumatology Biologics Register
- Abstract Number: 1427
The Importance of Outcome Measures in Ankylosing Spondylitis – Validity of the Routine Assessment of Patient Index Data 3 in a Real World Cohort
- Abstract Number: 540
The Importance of Outcome Measures in Rheumatoid Arthritis – Validity of the Routine Assessment of Patient Index Data 3 in a Real World Setting
- Abstract Number: 2346
The Improving Motivation for Physical Activity in Arthritis Clinical Trial for Adults with Knee Osteoarthritis and Rheumatoid Arthritis
- Abstract Number: 2900
The Incidence and Prevalence of Systemic Sclerosis in Northwestern Part of Turkey
- Abstract Number: 1501
The Incidence of Interstial Lung Disease and Malignancies in Veterans with Rheumatoid Arthritis
- Abstract Number: 1309
The Incidence of Sexually Acquired Reactive Arthritis: A Systematic Literature Review
- Abstract Number: 2296
The Influence of Androgen Deprivation Therapy on Serum Uric Acid Level
- Abstract Number: 395
The Influence of Early Achievement of “Clinically Inactive Disease” or “Minimal Disease Activity” on Long-Term Disability Outcomes in JIA
- Abstract Number: 2272
The Influence of Genetic Variants on Renal Uric Acid Excretion in Response to Frusemide
- Abstract Number: 447
The Influence of Risk Presentation Format on Willingness to Start a Medication
- Abstract Number: 3150
The Initial Dose of Methotrexate per Weight Is Determinant of Disease Activity and Early DAS28 Remission in DMARD-Naive Early Rheumatoid Arthritis Patients Receiving Usual Care
- Abstract Number: 185
The Interferon Gene Signature Is Increased in Early DMARD Naive Rheumatoid Arthritis and Predicts a Poorer Response to Initial Therapy
- Abstract Number: 791
The International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns (ICAP) Initiative – Update and Its Impact
- Abstract Number: 1899
The Intestinal Involvement in Systemic Sclerosis Is Characterized By a Peculiar Gut Microbiota
- Abstract Number: 2616
The JAK1-Selective Inhibitor Filgotinib Displays an Anti-Inflammatory Biomarker Signature in Rheumatoid Arthritis Patients
- Abstract Number: 2786
The Janus Kinase Inhibitor Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction
- Abstract Number: 1898
The Lack of Association of Osteoporosis with Proton Pump Inhibitor in Scleroderma: A UK Single Centre Cohort Experience
- Abstract Number: 654
The Level of B-Cell Active Cytokines and Soluble B-Cell Activating Factor/a Proliferation-Inducing Ligand Receptors in Patients with Primary Sjogren’s Syndrome
- Abstract Number: 2855
The Long-Term Clinical Outcomes of Lupus Nephritis
- Abstract Number: 747
The Long-Term Outcomes on Leflunomide Treatment in Patients with Lupus Nephritis: A Twelve-Year Follow-up Study
- Abstract Number: 2540
The Longitudinal Impact of Biologic Use on Disability within a RA Registry
- Abstract Number: 505
The Longitudinal Stability of the RA Biomarkers RF and ACPA in Classifying RA Subtypes over Extended Follow up
- Abstract Number: 2046
The Low-Dose Intravenous Cyclophosphamide Euro-Lupus Regimen Does Not Impact the Ovarian Reserve of Lupus Patients, As Measured By Serum Anti-Mullerian Hormone Levels
- Abstract Number: 2700
The Lymphatic System: A Gatekeeper for Migration of Pathogenic T-Cells Towards Synovial Joints and Entheses in Psoriasis
- Abstract Number: 440
the Majority of Biologic Injectors Are Stored Under Suboptimal Conditions at Home
- Abstract Number: 2145
The Modulation of Macrophage Polarization By SIRT1 Maybe New Target Therapy in Rheumatoid Arthritis
- Abstract Number: 1132
The Musculoskeletal Master Educator Training Program: A New Resource and Professional Development Opportunity for Leaders in Medical Education
- Abstract Number: 1825
the Non-Coding Genome and the Genetics of Systemic Lupus
- Abstract Number: 815
The Novel Anti-BICD2 Autoantibody Potentially Predicts a Favorable Disease Course in SSc
- Abstract Number: 2916
The Number of Micro-Haemorrhages and Micro-Thrombosis Detected By Nailfold Videocapillaroscopy Is a Good Predictor of Disease Activity in Systemic Sclerosis: The Validation Study of NEMO Score
- Abstract Number: 3098
The Occurrence of Peripheral Arthritis Mutilans in Psoriatic Arthritis Is Associated with Certain Major Histocompatibility Class I Alleles
- Abstract Number: 2243
The Paucity of the Evidence Base for American College of Rheumatology Practice Guidelines
- Abstract Number: 2536
The Performance of a Single Centre Interventional Clinic in Early Rheumatoid Arthritis
- Abstract Number: 2395
The Performance of the Kobayashi and Egami Scores in Detecting IVIG Resistance in Kawasaki Disease in a Single Centre Canadian Cohort Treated with IVIG and Low Dose Aspirin
- Abstract Number: 3129
The Pharmacokinetics of Oxypurinol in Patients Treated with Hemodialysis and Allopurinol
- Abstract Number: 900
The Phenotype of Macrophages in the Inflamed Vascular Wall of Giant Cell Arteritis Resembles the Phenotype of Non-Classical Monocytes
- Abstract Number: 2310
The Predictive Risk Factors for Complication of Infection during the Treatment for Inflammatory Myopathies Complicated with Interstitial Lung Disease
- Abstract Number: 1069
The Predictive Value of Acl and Anti-β2GPI in Patients with Acute Deep Vein Thrombosis
- Abstract Number: 2766
The Predictive Value of Patient’s and Evaluator’s Global Assessment and Tender and Swollen Joint Count Differences on Treatment Efficacy in Psoriatic Arthritis: Data from a Longitudinal Multicenter Study
- Abstract Number: 2793
The Predictors of Sustained Complete Remission in Lupus Nephritis
- Abstract Number: 1701
The Presence of Depression Might be an Important Determinant of Achieving Minimal Disease Activity State in Psoriatic Arthritis
- Abstract Number: 3
The Presence of Rheumatoid Factor Is Associated with Lower Bone Mass in Korean Health Screening Male Subjects without Clinically Apparent Arthritis
- Abstract Number: 2575
The Presence of Staphylococcal Toxins in the Urine of Patients with Rheumatoid Arthritis
- Abstract Number: 2102
the Prevalence and Associations of IgG/a/M ANTI-β2GPI and ANTI-Domain I Antibodies in an Antiphospholipid Syndrome (APS) Cohort of Patients from Turkey
- Abstract Number: 693
The Prevalence of Axial and Peripheral Spondyloarthritis in Inflammatory Bowel Disease: A Systematic Review & Meta-Analysis
- Abstract Number: 1295
The Prevalence of Inflammatory and Structural Lesions on MRI of the Sacroiliac Joints in Patients with Very Early Peripheral Spondyloarthritis
- Abstract Number: 433
The Prevalence of Latent Tuberculosis and Hepatitis B Found after Systematic Screening of Patients Starting with Biological Therapy in a Low-Endemic Area
- Abstract Number: 2495
The Prevalence of Loss of Response to Treatment with a Tumor Necrosis Factor Inhibitor and/or Methotrexate in Patients with Rheumatoid Arthritis
- Abstract Number: 2453
The Prevention, Screening, and Treatment of Congenital Heart Block from Neonatal Lupus: A Survey of Provider Practices
- Abstract Number: 1035
The Prognostic Value of Different Auto-Antibodies for Arthritis Development in Patients with Clinically Suspect Arthralgia
- Abstract Number: 2588
The Real World Comparative Safety of Certolizumab Pegol (CZP) As Compared to Other TNFi in a National US Cohort
- Abstract Number: 652
The Reasons for Discontinuation of Combination Therapy with Methotrexate and Tumor Necrosis Factor Inhibitors Versus Triple Therapy Differ Significantly Because of Higher Adverse Events with Triple Therapy
- Abstract Number: 814
The Regulatory B Cells Ameliorate Skin Sclerosis, Lung Fibrosis, and Autoimmunity Via an Anti-Oxidative Effect in Systemic Sclerosis Model Mice
- Abstract Number: 313
The Relation of Serum Urate to Radiographic Knee and Hand Osteoarthritis
- Abstract Number: 345
The Relationship Between Anti-Cyclic Citrullinated Peptide (anti-CCP) Levels and Bone Mineral Density (BMD) or Fragility Fracture in Patients with Rheumatoid Arthritis (RA)
- Abstract Number: 2338
The Relationship Between Anxiety and Physical Activity Participation in Adults with Persistent Knee Pain and the Moderating Effect of Neighborhood Social Cohesion
- Abstract Number: 506
The Relationship Between Elevations in CRP with Physical Function and Radiographic Progression over the Long-Term in Patients with Rheumatoid Arthritis
- Abstract Number: 1712
The Relationship Between Physical Functioning and Work for People with Psoriatic Arthritis: Results from a Large Real-World Study in 16 Countries
- Abstract Number: 529
The Relationship Between Promis and CDAI Scores, Disease Duration, Age and Gender in Patients with Rheumatoid Arthritis
- Abstract Number: 240
The Relationship Between Serum Cholinesterase, Number of Organ Involvement and Fibrotic Markers in Japanese Patients with IgG4-Related Disease
- Abstract Number: 117
The Relationship Between Socioeconomic Factors and Dmards Use in Rheumatoid Arthritis
- Abstract Number: 855
The Relationship Between Systemic Sclerosis and Breast Cancer and the Effects on Treatment Outcome
- Abstract Number: 495
The Relative Performance of 28-Joint Disease Activity Score Based on C-Reactive Protein with Three Versus Four Components in Patients with Rheumatoid Arthritis
- Abstract Number: 1274
The Reproducibility of a Semi-Automatic Algorithm in the Detection of Cortical Breaks and Adjacent Trabecular Bone Loss in Scan-Rescan Data from Patients with Early Arthritis
- Abstract Number: 1324
The Result of Follow-up Interferon-Gamma-Release Assays in Patients with Rheumatic Disease Receiving Biologic Agents in a Japanese Hospital
- Abstract Number: 1013
The Risk of Colchicine Associated Myopathy in Gout: Influence of Concomitant Use of Statin
- Abstract Number: 1705
The Risk of Fracture Among Patients with Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis
- Abstract Number: 402
The Risk of Hospitalized Infection Associated with Initiation of Abatacept Versus TNF Inhibitors in Juvenile Idiopathic Arthritis
- Abstract Number: 1074
The Risk of Obstetric Complications and the Effects of Treatment in Women with Low Titer and Medium-High Titer Anti-Phospholipid Antibodies
- Abstract Number: 1784
The Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Lupus Erythematosus: A Population-Based Study
- Abstract Number: 1993
The Risk of Stroke in Patients with Rheumatoid Arthritis and the Association with Competing Adverse Events
- Abstract Number: 336
The Risk of Subsequent Osteoporotic Fractures Is Decreased in Patients Experiencing Fracture While on Denosumab
- Abstract Number: 1022
The Risk of Symptomatic Knee Osteoarthritis after Arthroscopic Meniscus Repair Vs Partial Meniscectomy Vs the General Population
- Abstract Number: 818
The Role of Endothelin 1 in Activation of Vascular Smooth Muscle Cells in Systemic Sclerosis; Increased Cell Proliferation and Resistance to Apoptosis Mediated By Endotehlin B Receptors
- Abstract Number: 1749
The Role of Mucosal-Associated Invariant T (MAIT) Cells in Lupus Dermatitis
- Abstract Number: 1377
The Role of Muscle MRI in Detecting a Flare-up of Juvenile Dermatomyositis
- Abstract Number: 1574
The Role of Shelterin Deficiency in the Senescence in T Cells of Rheumatoid Arthritis
- Abstract Number: 1830
The Role of Tripartite Motif-Containing 21 in Interferon Signature of Systemic Lupus Erythematosus
- Abstract Number: 1361
The Role of Von Willebrand Factor Antigen As a Disease Biomarker in the Clinical Assessment of Children with Juvenile Dermatomyositis
- Abstract Number: 204
The Safety and Efficacy of Allopurinol Dose Escalation in People with Gout, a Randomised Controlled Trial
- Abstract Number: 200
The Safety and Efficacy of Benzbromarone in Gout in Aotearoa New Zealand
- Abstract Number: 970
The Serotonin Receptor 2 Inhibitor Terguride Has Beneficial Effects on Skin Fibrosis: Results from a Phase 2 Proof of Concept Study
- Abstract Number: 2587
The Serum Level of Reactive Oxygen Metabolities (ROM) at 12 Weeks during Treatment with Biologic Agents for Rheumatoid Arthritis Is a Predictor for the 52-Week Remission
- Abstract Number: 527
The Summed Bilateral Elbow Extension Angle in Rheumatoid Arthritis Correlates with the DAS28-CRP(4) and May be an Independent Marker of Bad Prognosis
- Abstract Number: 2906
The Survival and Prognostic Factors of Patients with Systemic Sclerosis Turkish Experience
- Abstract Number: 2015
The Systemic Sclerosis Disease State Is Associated with Specific Alterations in Gastrointestinal Microbiota in Two Independent Cohorts
- Abstract Number: 458
The TAM Receptors Axl and Mer Play a Protective Role in a Temporal and Spatial Manner in Inflammatory Arthritis
- Abstract Number: 668
The TNFAIP3 F127C Coding Variation in Sjogren’s Syndrome: Results from a Greek Cohort
- Abstract Number: 1909
The Transcription Factor Fra2 Is Playing a Key Role in Treg Development and Autoimmunity
- Abstract Number: 662
The Unusual Cross-Reactivity of Anti Muscarinic Receptor 3 Monclonal Antibodies Derived from Salivary Glands of Sjögren’s Syndrome Patients to Ro Peptides
- Abstract Number: 1186
The Use of Clinical Mucosal Manifestations to Differentiate Patients with Lupus and Dermatomyositis: Transversal, Retrospective and Analytical Study of 116 Patients
- Abstract Number: 781
The Use of Rituximab in Newly Diagnosed Systemic Lupus Erythematosus Patients: Long Term Steroid Saving Capacity and Clinical Effectiveness
- Abstract Number: 141
The Usefulness of SMI Technology on Ultrasound for the Evaluation of Active Synovitis in Patients with Rheumatoid Arthritis
- Abstract Number: 1290
The Usefulness of Volumetric Parameters of FDG PET/CT for Reflecting Disease Activity in Polymyositis/Dermatomyositis Patients
- Abstract Number: 889
The Utility of Patient-Reported Outcomes in Predicting Disease Activity in Patients with Takayasu’s Arteritis
- Abstract Number: 10
The Utility of Screening for Infectious Diseases in Recipients of Anti-TNF-α Therapy
- Abstract Number: 3181
The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis
- Abstract Number: 320
The Value of Adjusting for Physical Activity When Measuring Osteoarthritis-Related Pain
- Abstract Number: 2425
The Vasculopathy of Juvenile Dermatomyositis (JDM); Evidence of Persistent Endothelial Injury, Hypercoagulability, Subclinical Inflammation and Increased Arterial Stiffness
- Abstract Number: 1139
The Virtual Rheumatology Clinic: Virtual Patients for Resident Education in Rheumatology
- Abstract Number: 1447
Therapeutic Blockade of Interleukin-6 Trans-Signalling Restores Vascular Function in Murine Collagen Induced Arthritis
- Abstract Number: 2666
Therapeutic Efficacy of Iguratimod in Patients with Primary Sjogren’s Syndrome
- Abstract Number: 2889
Therapeutic Plasma Exchange for the Treatment of Raynaud’s and Digital Ulcers in Systemic Sclerosis: A Systematic Review
- Abstract Number: 1448
Therapeutic Role of a Novel Histone Deacetylase 6 Inhibitor, CKD-M808, in Rheumatoid Arthritis
- Abstract Number: 1905
Therapeutic Targeting of JAK/STAT Pathway Inhibits Follicular Helper T Cell Maturation and Function
- Abstract Number: 617
Therapy in Patients with Rheumatoid Arthritis (RA) with Inadequate Response to Tumor Necrosis Factor Alpha Inhibitors (TNFi): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs
- Abstract Number: 2605
Therapy with Biologic Agents after Diagnosis of Solid Malignancies; Results from the Corrona Registry
- Abstract Number: 560
There Is No Further Gain from Calculating Disease Activity Score in 28 Joints with High Sensitivity Assays of C-Reactive Protein Because of High Intraindividual Variability of CRP: A Cross Sectional Study and Theoretical Consideration
- Abstract Number: 2308
Thigh Muscle MRI Reveals Extensive Muscle Edema and Early Fatty Replacement in Patients with Immune-Mediated Necrotizing Myopathy
- Abstract Number: 1175
Thirty Day Readmission Rates for Patients Diagnosed with Systemic Lupus Erythematosus: Analysis at a Tertiary Care Center
- Abstract Number: 2080
Three Simple Tests to Raise the Index of Suspicion for Fibromyalgia in Primary Care
- Abstract Number: 2505
Thresholds of Benefit-Risk Trade-Offs from the Patient Perspective for Treatment Decisions in Moderate-to-Severe Rheumatoid Arthritis
- Abstract Number: 2964
Thromboangiitis Obliterans (Buerger’s disease) : An Observational Study of 174 Patients
- Abstract Number: 1963
Thrombospondin-1 Is Elevated in the Plasma of Patients with Antiphospholipid Syndrome and Is Correlated with Free Active TGF-b1 Levels, IL-1b and IL-17A
- Abstract Number: 653
Thrombospondin-1 Is Highly Expressed By Salivary Gland Epithelial Cells of Sjögren’s Syndrome Patients, Both Constitutively and upon Exposure to Necrotic Cells Debris
- Abstract Number: 2597
Time to Initiation of Biologic Agents Is Associated with Glucocorticoid Use: Results from the Corrona Registry
- Abstract Number: 840
Time Trends in Incidence and Mortality of Systemic Sclerosis in Denmark from 1995-2011: A Nationwide Cohort Study
- Abstract Number: 2711
Tissue-Resident IL-23 Responsive Innate T Cells in Mice Comprise Tcrαβ+ and TCRγδ+ Subsets with Overlapping Function
- Abstract Number: 2057
TLR-7-Mediated Lupus Nephritis Flares Are Independent of Type I Interferon Signaling
- Abstract Number: 2526
TNF Blocker Concentrations or Detection of Antibodies Against Anti-TNF before a Tapering Process Are Not Predictive to Relapse
- Abstract Number: 1922
TNF-α and IL-6 Induced Upregulation of CCR5 and CXCR3 Participate in Vδ2 Chemotaxis in RA
- Abstract Number: 1682
Tnfα Inhibitors Are Associated with Reduced Progression of Carotid Atherosclerotic Plaques By Ultrasound and an Improvement in Aortic Arch Vascular Inflammation By 18-FDG PET/CT in Psoriasis and Psoriatic Arthritis Patients – a Prospective Study from Two Cohorts
- Abstract Number: 2499
Tocilizumab Achieves Rapid Reduction of Disease Activity and Has Beneficial Effects on Bone Mineral Density in Patients with Rheumatoid Arthritis
- Abstract Number: 977
Tocilizumab As an Add-on Therapy to Glucocorticoids during the First 3 Months of Treatment of Giant Cell Arteritis: Results of a French Multicenter Prospective Open-Label Study
- Abstract Number: 3183
Tocilizumab for the Treatment of Giant Cell Arteritis – MR-Angiography Results from the First Randomized Placebo-Controlled Trial
- Abstract Number: 1336
Tocilizumab for Uveitic Cystoid Macular Edema Refractory to Other Synthetic and Biological Immunosuppressive Drugs. Multicenter Study of 25 Patients
- Abstract Number: 955
Tocilizumab Infusion Intervals Can be Extended to 5 or 6 Weeks in RA Patients Who Sustained Low Disease Activity By 4 Weeks Interval of Tocilizumab Infusion
- Abstract Number: 2502
Tocilizumab Therapy Reduces Corrected QT Interval in Patients with Rheumatoid Arthritis without Cardiac Symptoms
- Abstract Number: 2580
Tofacitinib Do Not Get Worse Subclinical Atherosclerosis Despite up-Regulating Serum Cholesterol in Methotrexate-Resistant Active Rheumatoid Arthritis Patients
- Abstract Number: 2600
Tofacitinib Is Associated with an Impaired Function of NK Cells and a Defective Immunosurveillance Against B-Cell Lymphomas
- Abstract Number: 1438
Tofacitinib Restores Reverse Cholesterol Transport Inhibition Induced By Inflammation. Understanding the Lipid Paradox
- Abstract Number: 1647
Tofacitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-Label, Long-Term Extension Studies over 8 Years
- Abstract Number: 1643
Tofacitinib: Treatment Outcomes in Seropositive Versus Seronegative Patients in a Phase 3 RA Population
- Abstract Number: 1661
Toll-like Receptor 4 Induced IL-20 and IL-24 Stimulate Osteoblast Mineralization and Are Increased in Spondyloarthritis
- Abstract Number: 2300
Tophaceous Gout and the Risk of Mortality: A General Population-Based Study
- Abstract Number: 2357
Topical Application of Aceclofenac Might NOT Produce a Significant Increase of Blood Pressure in Osteoarthritic Patients – a Continuous Automated Blood Pressure Monitor Study
- Abstract Number: 3167
Total and Glucocorticoid-Related Damage Accrual in the Systemic Lupus International Collaborating Clinics Inception Cohort
- Abstract Number: 1406
Towards Harmonized Data Collection in Rheumatoid Arthritis (RA): The EULAR Task Force for Standardizing a Minimum Data Collection for RA Observational Research
- Abstract Number: 2196
Trajectories and Predictors of Fear-Avoidance in Persons with Rheumatoid Arthritis. a Longitudinal Observational Study
- Abstract Number: 2273
Trans-Ancestral Meta-Analysis Identifies Nine New Loci Associated with Serum Uric Acid Concentrations
- Abstract Number: 2138
Transcriptional Analysis of Synovial Tissue Reveals Sustained Inflammatory Chemokine Expression Despite Minimal Histopathologic Change in the Destabilization of Medial Meniscus Model of Murine Knee Osteoarthritis
- Abstract Number: 1200
Transcriptional Profiling of Early RA Synovial Tissue Reveals the Impact of Triple DMARD Treatment on T Cell Activation Pathways
- Abstract Number: 2455
Transcriptome Profile of Cells Isolated from a CHB Heart Support an Exuberant Inflammatory ⁄Pro-Fibrotic Cascade
- Abstract Number: 2426
Transcriptomic Analysis of Immune Subsets in Juvenile Dermatomyositis before and after Treatment Identifies Novel Pathways Involved in Pathogenesis
- Abstract Number: 96
Transforming Healthcare in Rheumatology: From Inpatient to Outpatient Care without Reductions in Healthcare Quality
- Abstract Number: 1575
Transient Circulatory Existence of Multipotential Stromal Cells Is Unlikely to Contribute to the Pathogenesis of Rheumatoid Arthritis
- Abstract Number: 2131
Transient Receptor Potential Ankyrin 1 (TRPA1) Is Functionally Expressed in Primary Human Osteoarthritic Chondrocytes and Mediates Cartilage Destruction and Joint Pain in the Mia-Model of Osteoarthritis
- Abstract Number: 2903
Transition of Nailfold Microangiopathy throughout Different Patterns of Microvascular Damage and Correlations with Organ Involvement in Systemic Sclerosis: A Twelve Year Follow-up
- Abstract Number: 1399
Transitioning Lupus Patients from Pediatric to Adult Rheumatology
- Abstract Number: 2785
Translatable in Vitro Immunocyte Functional Measures of CC-292 and CC-90008 Inhibitors of the Bruton’s Tyrosine Kinase (Btk)/Tec Family and the Pathology Observed in the MLR/Lpr Mouse Model of Systemic Lupus Erythematosus (SLE)
- Abstract Number: 2470
Treat to Target: Theoretical Agreement Vs Daily Applicability
- Abstract Number: 3212
Treat-to-Target in RA: Does Early Simplified Disease Activity Index (SDAI) Remission Lead to Better 5-Year Functional Outcomes Than SDAI Low Disease Activity?
- Abstract Number: 1700
Treating Psoriatic Arthritis (PsA) to Target: Defining Psoriatic Arthritis Disease Activity Score (PASDAS) That Reflects Disease Activity in Psa
- Abstract Number: 898
Treatment and Outcome of Patients with a Diagnosis of Healed Arteritis on Temporal Artery Biopsy
- Abstract Number: 3067
Treatment Decisions Following Diagnosis of Cancer during TNFi Inhibitor Treatment in Patients with Rheumatoid Arthritis: Results from the BSRBR-RA
- Abstract Number: 1928
Treatment of ANCA Associated Vasculitis in the Very Elderly
- Abstract Number: 1453
Treatment of BAFF Transgenic Mice with Anti-TNF: Monoclonals Are Associated with a Higher Risk of Lymphoma Than Etanercept
- Abstract Number: 2977
Treatment of Cryoglobulinemic Vasculitis with Sofosbuvir in Four Combination Protocols
- Abstract Number: 963
Treatment of Homocysteine Improves Urine Protein/Cr Ratio in SLE
- Abstract Number: 2694
Treatment of ZAP-70 Mutant SKG Mice with Anti-IL-23 Antibody Alters Fecal Microbiota Composition and Prevents Outgrowth of Bacteria Associated with Susceptibility to Spondyloarthritis and Ileitis
- Abstract Number: 84
Treatment Outcomes and Predictors of Patient Support Program Use Among Patients with Rheumatoid Arthritis: Results from a Post-Marketing Observational Study (PMOS)
- Abstract Number: 2225
Treatment Outcomes of Newly and Formerly Diagnosed Patients with Fibromyalgia after Fibromyalgia Treatment Program
- Abstract Number: 2729
Treatment Patterns, Unmet Need, and Impact of Psoriatic Arthritis on Patient-Reported Outcomes in the United States
- Abstract Number: 2253
Treatment Persistence with Subcutaneous TNF-Alpha Inhibitors in France
- Abstract Number: 1588
Treatment with BI 655064 (Antagonistic Anti-CD40 Antibody) Modulates Clinical and Biomarker Parameters Associated with Rheumatoid Arthritis (RA)
- Abstract Number: 177
Treatment with Dexamethasone and Monophosphoryl Lipid a Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers the Ability to Modulate CD4+ T Cell Responses
- Abstract Number: 702
Treatment with Golimumab or Infliximab Reduces Health Resource Utilization and Increases Work Productivity in Patients with Ankylosing Spondylitis in a Large, Prospective Real-Life Cohort
- Abstract Number: 906
Treatment with Methotrexate and Risk of Relapses in Patients with Giant Cell Arteritis in Clinical Practice
- Abstract Number: 1617
Treatment with Sirukumab, an Anti-IL6 Cytokine Monoclonal Antibody, Improves Fatigue and Health-Related Physical and Emotional Well Being in Patients with Active Rheumatoid Arthritis Refractory to Conventional or Biologic Therapy: Results of 2 Global, Placebo-Controlled, Phase 3 Trials
- Abstract Number: 2104
Treatment with Tocilizumab Decreases CXCL13 Expression in Cultured Temporal Arteries from Patients with Giant Cell Arteritis
- Abstract Number: 1650
Treatment with Tofacitinib Inhibits Human Naive B Lymphocyte Development and Function in Vitro
- Abstract Number: 1044
Treatment with Tofacitinib Is Associated with Clinically Meaningful Reductions in Axial MRI Inflammation in Patients with Ankylosing Spondylitis
- Abstract Number: 2645
Treatments for Early Rheumatoid Arthritis (RA): A Systematic Review of Randomized Controlled Trials
- Abstract Number: 2433
Trends in Use of Hydroxychloroquine during Pregnancy in SLE Patients from 2001 to 2012
- Abstract Number: 2986
Trends and Determinants of Osteoporosis Prevention and Management in Patients with Rheumatoid Arthritis Compared to Osteoarthritis
- Abstract Number: 2631
Trends and Factors Associated with Use of Biologic Agents As Monotherapy Among US Patients with Rheumatoid Arthritis
- Abstract Number: 2303
Trends in Gout and Rheumatoid Arthritis Hospitalizations in Canada from 2000-2011
- Abstract Number: 1505
Trends in Hospitalizations for Infections in US Patients with Rheumatoid Arthritis, 1993-2013
- Abstract Number: 2331
Trends in Joint Replacement Surgery in Patients with Rheumatoid Arthritis
- Abstract Number: 1365
Trends in Medication Usage in Patients with Juvenile Dermatomyositis
- Abstract Number: 1510
Trends in the Occurrence of Malignancy in Japanese Patients with Rheumatoid Arthritis Based on the Institute of Rheumatology, Rheumatoid Arthritis (IORRA) Cohort during a 14-Year Observation Period
- Abstract Number: 568
Triggering Receptor Expressed on Myeloid Cells (TREM) As a Novel Indicator of Disease Progression in ‘at-Risk’ Individuals
- Abstract Number: 2581
Tripterygium Wilfordii Hook F Applied Topically in Patients with Active Rheumatoid Arthritis
- Abstract Number: 1675
Triptolide Inhibits Th17 Differentation By JAK2/STAT3 Signal Pathway in Inflammation of Ankylosing Spondylitis
- Abstract Number: 2006
Tuberculosis Incidence in Ankylosing Spondylitis, Psoriatic Arthritis, and Other Spondyloarthropathies in Sweden: A Population-Based Cohort Study
- Abstract Number: 964
Tubulointerstitial Damage Is an Independent Predictor of End Stage Renal Disease in Lupus Nephritis Patients with Mild to Moderate Renal Impairment
- Abstract Number: 2557
Tumor Necrosis Factor (TNF) Sensitizes Rheumatoid Synovial Fibroblasts to TRPA1-Mediated Calcium Flux, Anti-Proliferation and Cell Death
- Abstract Number: 2982
Tumor Necrosis Factor Inhibitors and the Risk of Malignancy in the Treatment of Juvenile Idiopathic Arthritis
- Abstract Number: 1129
Tumor Necrosis Factor Receptor 2 Is Crucial for Regulatory T Cells Activity with Consequences in a Model of Chronic Inflammation and in Anti-TNF Treated Rheumatoid Arthritis
- Abstract Number: 382
Tumor Necrosis Factor-α -308 a/G Gene Polymorphism in Children with Juvenile Idiopathic Arthritis: Relation to Disease Activity, Damage and Disability
- Abstract Number: 19
Tumour Necrosis Factor Inhibition Is Associated with Weight Gain in Patients with Inflammatory Arthritis
- Abstract Number: 2708
Type 17 Immunity in Spondyloarthritis Is Expanded Across Multiple Lymphocyte Subsets
- Abstract Number: 2068
Type 2 Innate Lymphoid Cells – Cellular Source of Profibrotic Mediators Rapidly and Persistently Recruited in Experimental Fibrosis and Systemic Sclerosis
- Abstract Number: 1669
Type 3 Innate Lymphoid Cells Numbers in Peripheral Blood Predict Ustekinumab (Stelara) Therapy Responsiveness in Psoriatic Disease Cases with Subclinical Imaging Enthesopathy
- Abstract Number: 1340
Type and Frequency of Immune-Related Adverse Reactions in Patients Treated with Pembrolizumab (Keytruda), a Monoclonal Antibody Directed Against PD-1, in Advanced Melanoma at a Single Institution
- Abstract Number: 1827
Type I IFN Signature Low and High SLE Subjects with Moderate to Severe Disease Activity Have Distinct Gene Expression Signatures of Immunologic Pathways and Cell Types
- Abstract Number: 1082
Type I/II Interferon Commits to Abnormal Expression of Chemokine Receptor on B Cells in Patients with Systemic Lupus Erythematosus
- Abstract Number: 479
Type II Collagen Secreted from Articular Chondrocytes Is Mainly Destroyed By Cathepsin S in RA Mice
2016 ACR/ARHP Annual Meeting
November 11-16, 2016. Washington, DC.